JenaValve Technology, Inc.

📣Don't Miss Out!   Tomorrow is the night — the ASE Live Journal Club Session will be taking a deep dive into the evolving management of Aortic Regurgitation, with a focus on the critical role of echocardiography in accurate assessment and clinical decision-making.   📅 Wednesday, April 23rd 🕙 8 - 9 PM EST 🔗 Register here: https://lnkd.in/gqsWsxXi   Moderated by Nadeen N. Faza, MD, FACC, FASE, FSCAI and Priscilla Wessly with expert guest authors Vidhu Anand and Patricia Pellikka, MD — this session is a must-attend for the echo community and anyone managing patients with AR.   #AorticRegurgitation #TAVR #StructuralHeart #EchoFirst #JASE #CMR #Echocardiography #CardiacImaging

Presented at #GulfPCR! This recorded case showcases Trilogy implantation in an LVAD ❤️ patient with severe aortic regurgitation (AR) 🔄. Watch the expert approach to tackling this complex case! Jump to ▶️ 1:11:30 to see the JenaValve case in action! 👀🔬 https://bit.ly/4jeWoGN

Live Educational Session | The American Society of Echocardiography will be hosting an X-exclusive deep dive discussion on the evolving landscape of Aortic Regurgitation management. This session will complement the recent JASE review "Noninvasive Imaging for Native Aortic Valve Regurgitation" which emphasizes the critical role of imaging, particularly echocardiography, in AR assessment and decision-making. Don't miss this expert-led discussion moderated by Nadeen N. Faza, MD, FACC, FASE, FSCAI and Priscilla Wessly. Guest authors include Vidhu Anand and Patricia Pellikka, MD. 📅 Wednesday, April 23rd 🕙 8 - 9 PM EST 🔗 Register here: https://lnkd.in/gqsWsxXi #AorticRegurgitation #TAVR #StructuralHeart #JASE #EchoFirst #CardiacImaging #CMR

🎓 Don’t miss Part 2 this important webinar from American Society of Echocardiography! “The Evolving Role of Echocardiography in Aortic Regurgitation” dives into the complexities of accurately diagnosing AR severity by echocardiography — a common and often challenging issue in clinical practice.   Register for Part 2 of the series below: https://t.co/8dDoU8geoC   #Echocardiography #AorticRegurgitation #StructuralHeart #ASE #CardiologyEducation #ValvularHeartDisease #ARdiagnosis  

From #ACC25, as presented by Dr. Rak Makkar - in 500 patients enrolled in the ALIGN-AR trial (PMA + continued access), the primary safety and efficacy outcomes achieved performance goals, consistent with what we reported in the initial 180 patient PMA study. Thank you to all the investigators of this pivotal study! CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.

Quantification of aortic regurgitation by echo is complex! Insights from the experts can make all the difference. Tune in April 10th, for part 2 of this important webinar series from American Society of Echocardiography. 🗓️Register now: https://t.co/8dDoU8geoC #AorticRegurgitation #echocardiography #Cardiology

Breaking new ground in Montreal, Canada! We're proud to share that the first ever Trilogy cases have been completed in Canada! A huge thank you to the pioneering heart teams at Montreal Heart Institute for their dedication and expertise in making this possible. This achievement paves the way for expanded access to innovative care for patients across Canada. Univ.-Prof.Dr. Ralph Stephan von Bardeleben, MD FESC Walid Ben Ali MD PhD FRCSC #Trilogy #AorticRegurgitation #JenaValve #TAVR CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.

Late breaking presentation from #ACC25! Jenavalve presents outcomes from the first 500 patients in the ALIGN-AR Trial, marking the largest, prospective study of a dedicated TAVR device in patients with severe aortic regurgitation. Don’t miss the details in our latest press release: https://bit.ly/3DPvIgx #ALIGNAR #JenaValve #Trilogy #TAVR #AorticRegurgitation

Breaking news from #ACC25! Join us for a Late-Breaking Clinical Trials session as Dr. Raj Makkar presents clinical outcomes from 500 patients treated in ALIGN-AR—the first pivotal study evaluating a dedicated TAVR device for severe aortic regurgitation in high-risk patients. 🗓️ March 30
 🕙 10:15 – 10:25 AM
 📍 Main Tent #ACC25 #ALIGNAR #TAVR #AorticRegurgitation #Latebreaking

JenaValve is unveiling important clinical results from the ALIGN-AR Trial in a Late-Breaking Clinical Trials session. Join us at #ACC25 on Sunday, March 30th to be part of the conversation!   Don't miss the opportunity to explore innovations in transcatheter valve technology that are advancing treatment of aortic regurgitation. #JenaValve #ACC25 #Cardiology #LateBreaking #ClinicalTrials